The most common grade @-@ adverse events were neutropenia ( @ -LSB- @ % -RSB- of @ patients in the everolimus group vs @ -LSB- @ % -RSB- of @ patients in the placebo group ) , leucopenia ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ) , anaemia ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ) , febrile neutropenia ( @ -LSB- @ % -RSB- vs ten -LSB- @ % -RSB- ) , stomatitis ( @ -LSB- @ % -RSB- vs four -LSB- @ % -RSB- ) , and fatigue ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ) .